Business ❯ Biotechnology

Pharmaceuticals

Drug Development Vaccine Development Clinical Trials Acquisitions Immunotherapy Cancer Treatment Oncology Clinical Research Manufacturing Gene Therapy

FDA Panel Rejects Deramiocel Cardiac Claim After Lancet Publishes HOPE‑3 Results

A 9–3 advisory vote and critical FDA reviews increase doubt about final approval ahead of the August 22 PDUFA date.

Multiple Law Firms File Competing Securities Suits Against ADMA Biologics

Vertex to Acquire Crinetics for About $10 Billion

Novartis to Acquire Myricx Bio for Up to $1.5 Billion

Takeda Signs $600 Million‑Value AI Drug Discovery Deal With Insilico

Definium’s Oral LSD Pill Meets Primary Endpoint in Phase 3 Depression Trial

Biogen to Buy RayThera for Up to $1 Billion

FDA Panel Weighs Moderna’s Bid for First U.S. mRNA Flu Vaccine

Moderna Restructures Leadership as It Prepares for Multiple Vaccine Launches

Moderna Signals Interest in Buying Biontech's German Plants

Securities Suit Filed Against ADMA Biologics After Short‑Seller Report

New Oral Drug Nearly Doubles Survival for Treated Metastatic Pancreatic Cancer

Lilly Wins Exclusive License to Ascidian RNA Exon-Editing Platform for Kidney Diseases

Servier to Buy Edgewise Muscular Dystrophy Unit for Up to $2.65 Billion

Colombia Signs Deal With SK Bioscience to Build Domestic Vaccine Production

Investors Vie to Lead ImmunityBio Securities Suit

Akari’s AKTX-101 Shows Preclinical Synergy With KRAS Inhibitor as Stock Soars

ImmunityBio Investor Lawsuits Push Toward May 26 Lead-Plaintiff Deadline

ImmunityBio Investors Face May 26 Lead-Plaintiff Deadline in Securities Suit Tied to FDA Anktiva Rebuke

BioNTech to Shut Multiple Sites, Put 1,860 Jobs at Risk in Pivot to Cancer